Target product selection - where can Molecular Pharming make the difference?
about
Putting the Spotlight Back on Plant Suspension CulturesN-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.A Systematic Analysis of the Structures of Heterologously Expressed Proteins and Those from Their Native Hosts in the RCSB PDB Archive.Comparative evaluation of recombinant protein production in different biofactories: the green perspective.Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.Glyco-engineering for biopharmaceutical production in moss bioreactors.Rice seed for delivery of vaccines to gut mucosal immune tissues.Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector.Synthetic gene design-The rationale for codon optimization and implications for molecular pharming in plants.Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants.Rice endosperm produces an underglycosylated and potent form of the HIV-neutralizing monoclonal antibody 2G12.Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody.Plant species and organ influence the structure and subcellular localization of recombinant glycoproteins.Animal component-free Agrobacterium tumefaciens cultivation media for better GMP-compliance increases biomass yield and pharmaceutical protein expression in Nicotiana benthamiana.Cloning and plant-based production of antibody MC10E7 for a lateral flow immunoassay to detect [4-arginine]microcystin in freshwater.Recombinant biosynthesis of functional human growth hormone and coagulation factor IX in transgenic soybean seeds.Contained Molecular Farming Using Plant Cell and Tissue Cultures
P2860
Q26750974-02A93162-5F0C-4FD6-946B-5A5A0DEC77B5Q35003962-43E608E2-C3CE-4F4D-91BE-3C84874C5FF8Q36102601-EC97CDE4-759E-4668-9FFB-7DCE7AC897C7Q37679720-DDCA66D9-A9B7-4842-A450-BE65FB6485D1Q38174581-720DFDB3-9EBA-4652-93AA-72686CBEA07DQ38232409-4490686C-BA04-42D8-BCD6-61710FDCE822Q38234961-B8ED517F-16EC-438E-9F05-64464A6A9EAAQ38534952-F44EF46C-BDD3-4B32-818F-3BCD225DD784Q38542407-7E6C242E-6719-49C3-A3F8-90945F6C4DFEQ38951951-F5E55EF3-2EF5-486E-BDA5-B7489361A449Q40766118-91E578BD-AF84-41BF-BC68-1437A36194D1Q41111458-1AD70F44-1E19-4598-AB9C-5C2BD518A914Q44296089-759E1E31-2A07-4E5B-B9C6-139420CED036Q45021927-BA523E4F-CC7F-4F99-B2E7-2188FE98E5C8Q46414715-841CCC2E-14F9-4127-AD92-D1C61F63F62CQ49747358-2BEFC738-6038-461A-8E62-39538590FAF8Q55714735-888FDFEC-2C35-4FAC-A095-D7AE07127F4EQ57694977-3DB75BE3-5464-44FC-90CD-1BE43C4A81D5
P2860
Target product selection - where can Molecular Pharming make the difference?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Target product selection - where can Molecular Pharming make the difference?
@en
type
label
Target product selection - where can Molecular Pharming make the difference?
@en
prefLabel
Target product selection - where can Molecular Pharming make the difference?
@en
P2093
P1476
Target product selection - where can Molecular Pharming make the difference?
@en
P2093
Audrey Y H Teh
Julian K-C Ma
Mathew J Paul
Richard M Twyman
P304
P356
10.2174/1381612811319310003
P577
2013-01-01T00:00:00Z